GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Burjeel Holdings PLC (ADX:BURJEEL) » Definitions » EV-to-EBIT

Burjeel Holdings (ADX:BURJEEL) EV-to-EBIT : 20.65 (As of Jun. 02, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Burjeel Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Burjeel Holdings's Enterprise Value is د.إ9,984 Mil. Burjeel Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was د.إ484 Mil. Therefore, Burjeel Holdings's EV-to-EBIT for today is 20.65.

The historical rank and industry rank for Burjeel Holdings's EV-to-EBIT or its related term are showing as below:

ADX:BURJEEL' s EV-to-EBIT Range Over the Past 10 Years
Min: 18.07   Med: 24.43   Max: 33.26
Current: 20.65

During the past 6 years, the highest EV-to-EBIT of Burjeel Holdings was 33.26. The lowest was 18.07. And the median was 24.43.

ADX:BURJEEL's EV-to-EBIT is ranked worse than
59.73% of 452 companies
in the Healthcare Providers & Services industry
Industry Median: 16.79 vs ADX:BURJEEL: 20.65

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Burjeel Holdings's Enterprise Value for the quarter that ended in Mar. 2025 was د.إ9,984 Mil. Burjeel Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was د.إ484 Mil. Burjeel Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 4.84%.


Burjeel Holdings EV-to-EBIT Historical Data

The historical data trend for Burjeel Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burjeel Holdings EV-to-EBIT Chart

Burjeel Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial - - 25.09 26.94 23.22

Burjeel Holdings Quarterly Data
Mar21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.97 24.81 22.56 23.22 20.65

Competitive Comparison of Burjeel Holdings's EV-to-EBIT

For the Medical Care Facilities subindustry, Burjeel Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Burjeel Holdings's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Burjeel Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Burjeel Holdings's EV-to-EBIT falls into.


;
;

Burjeel Holdings EV-to-EBIT Calculation

Burjeel Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9983.944/483.567
=20.65

Burjeel Holdings's current Enterprise Value is د.إ9,984 Mil.
Burjeel Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ484 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Burjeel Holdings  (ADX:BURJEEL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Burjeel Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=483.567/9983.94328
=4.84 %

Burjeel Holdings's Enterprise Value for the quarter that ended in Mar. 2025 was د.إ9,984 Mil.
Burjeel Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ484 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Burjeel Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Burjeel Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Burjeel Holdings Business Description

Traded in Other Exchanges
N/A
Address
402-D02, Abu Dhabi Global Market Square, 15th Floor, Al Sarab Tower, Maryah Island, Abu Dhabi, ARE
Burjeel Holdings PLC is a healthcare service provider. Along with its subsidiaries, it provides multi-specialty hospitals, medical, surgical and dental services, and the sale of pharmaceutical goods and medical equipment. The group's reportable segments are Hospitals, Medical Centre, Pharmacies, and Others. Maximum revenue for the group is derived from the Hospitals segment, which includes entities that provide inpatient, day-care services, and outpatient services to patients to diagnosis the disease and offer medical and surgical treatment as part of in-patient services. Geographically, it derives maximum revenue from its customers in the United Arab Emirates, followed by the Sultanate of Oman and the Kingdom of Saudi Arabia.

Burjeel Holdings Headlines

No Headlines